Dallas, TX: ReportsandReports announce it will carry Japan In Vitro Diagnostics Market Outlook to 2016 Market Research Report in its Store.
Browse complete Report on: http://www.reportsandreports.com/market-reports/japan-in-vitro-diagnostics-market-outlook-to-2016/
Report Summary
GlobalData’s new report, “Japan In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Japan In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
* Market size and company share data for In Vitro Diagnostics (IVD) market categories clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.
* Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
* 2009 company shares and distribution shares data for each of the seven market categories.
* Global corporate-level profiles of key companies operating within the Japan In Vitro Diagnostics (IVD) market.
* Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.
Reasons to buy
* Develop business strategies by identifying the key market categories and segments poised for strong growth.
* Develop market-entry and market expansion strategies.
* Design competition strategies by identifying who-stands-where in the Japan In Vitro Diagnostics (IVD) competitive landscape.
* Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
* What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 15
2.1 What is This Report About? 15
3 In Vitro Diagnostics In Japan 16
3.1 In Vitro Diagnostics, Market Segmentation 16
3.2 In Vitro Diagnostics, Japan, Overall Revenue ($m), 2002-2016 17
3.3 In Vitro Diagnostics Market, Japan, Revenue Mix ($m), 2009 19
3.4 In Vitro Diagnostics Market, Japan, Category Contribution (%), 2009 20
3.5 In Vitro Diagnostics, Japan, Company Share (2008-2009) 26
4 Clinical Chemistry In Japan 28
4.1 Clinical Chemistry, Market Segmentation 28
4.2 Clinical Chemistry Market, Japan, Revenue Mix ($m), 2009 29
4.3 Clinical Chemistry Market, Japan, Category Contribution (%), 2009 30
4.4 Clinical Chemistry Overall Revenue (2002-2016) 31
4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016) 35
4.4.2 Urine Analysis Revenue (2002-2016) 38
4.5 Clinical Chemistry Distribution Share (2008-2009) 42
4.6 Clinical Chemistry, Japan, Company Share (2008-2009) 43
5 Genetic Testing In Japan 45
5.1 Genetic Testing, Market Segmentation 45
5.2 Genetic Testing Market, Japan, Revenue Mix ($m), 2009 46
5.3 Genetic Testing Market, Japan, Category Contribution (%), 2009 47
5.4 Genetic Testing Overall Revenue (2002-2016) 48
5.5 Genetic Testing Distribution Share (2008-2009) 52
5.6 Genetic Testing, Japan, Company Share (2008-2009) 53
6 Haematology In Japan 55
6.1 Haematology, Market Segmentation 55
6.2 Haematology Market, Japan, Revenue Mix ($m), 2009 56
6.3 Haematology Market, Japan, Category Contribution (%), 2009 57
6.4 Haematology Overall Revenue (2002-2016) 58
6.4.1 Haematology Reagents Revenue (2002-2016) 62
6.4.2 Immunohaematology Revenue (2002-2016) 66
6.4.3 Haemostasis Revenue (2002-2016) 70
6.4.4 Haematology Rapid Tests Revenue (2002-2016) 74
6.4.5 Haematology Cell Counters Revenue (2002-2016) 78
6.5 Haematology Distribution Share (2008-2009) 82
6.6 Haematology, Japan, Company Share (2008-2009) 83
7 Histology And Cytology In Japan 85
7.1 Histology and Cytology, Market Segmentation 85
7.2 Histology and Cytology Market, Japan, Revenue Mix ($m), 2009 86
7.3 Histology and Cytology Market, Japan, Category Contribution (%), 2009 87
7.4 Histology And Cytology Overall Revenue (2002-2016) 88
7.4.1 Histology Revenue (2002-2016) 92
7.5 Histology And Cytology Distribution Share (2008-2009) 96
7.6 Histology And Cytology, Japan, Company Share (2008-2009) 97
8 Immuno Chemistry In Japan 99
8.1 Immuno Chemistry, Market Segmentation 99
8.2 Immuno Chemistry Market, Japan, Revenue Mix ($m), 2009 100
8.3 Immuno Chemistry Market, Japan, Category Contribution (%), 2009 101
8.4 Immuno Chemistry Overall Revenue (2002-2016) 102
8.4.1 Disease Specific Immunochemistry Revenue (2002-2016) 106
8.4.2 Drug Related Testing Revenue (2002-2016) 110
8.4.3 Endocrinology Tests Revenue (2002-2016) 114
8.4.4 Immunochemistry Analyzers Revenue (2002-2016) 118
8.5 Immuno Chemistry Distribution Share (2008-2009) 122
8.5.1 Immuno Chemistry, Japan, Company Share (2008-2009) 123
9 Infectious Immunology In Japan 125
9.1 Infectious Immunology, Market Segmentation 125
9.2 Infectious Immunology Market, Japan, Revenue Mix ($m), 2009 126
9.3 Infectious Immunology Market, Japan, Category Contribution (%), 2009 127
9.4 Infectious Immunology Overall Revenue (2002-2016) 128
9.5 Infectious Immunology Distribution Share (2008-2009) 132
9.6 Infectious Immunology, Japan, Company Share (2008-2009) 133
10 Microbiology Culture In Japan 135
10.1 Microbiology Culture, Market Segmentation 135
10.2 Microbiology Culture Market, Japan, Revenue Mix ($m), 2009 136
10.3 Microbiology Culture Market, Japan, Category Contribution (%), 2009 137
10.4 Microbiology Culture Overall Revenue (2002-2016) 138
10.4.1 Microbiology Analyzers Revenue (2002-2016) 142
10.5 Microbiology Culture Distribution Share (2008-2009) 146
10.6 Microbiology Culture, Japan, Company Share (2008-2009) 147
11 Overview of Key Companies in Japan In Vitro Diagnostics Market 149
11.1 F. Hoffmann-La Roche Ltd. 149
11.1.1 Company Overview 149
11.1.2 Share in the Japan In Vitro Diagnostics Market 149
11.2 Siemens Healthcare 150
11.2.1 Company Overview 150
11.2.2 Share in the Japan In Vitro Diagnostics Market 150
11.3 Sysmex Corporation 151
11.3.1 Company Overview 151
11.3.2 Share in the Japan In Vitro Diagnostics Market 151
11.4 Abbott Laboratories 152
11.4.1 Company Overview 152
11.4.2 Share in the Japan In Vitro Diagnostics Market 152
11.5 Beckman Coulter, Inc. 153
11.5.1 Company Overview 153
11.5.2 Share in the Japan In Vitro Diagnostics Market 153
11.6 Ortho-Clinical Diagnostics Inc. 154
11.6.1 Company Overview 154
11.6.2 Share in the Japan In Vitro Diagnostics Market 154
11.7 Inverness Medical Innovations, Inc. 155
11.7.1 Company Overview 155
11.8 Becton, Dickinson and Company 155
11.8.1 Company Overview 155
11.9 bioMerieux S.A. 156
11.9.1 Company Overview 156
11.10 Bio-Rad Laboratories, Inc. 156
11.10.1 Company Overview 156
11.11 Hologic, Inc. 157
11.11.1 Company Overview 157
11.12 OLYMPUS CORPORATION 157
11.12.1 Company Overview 157
11.13 Nihon Kohden Corporation 158
11.13.1 Company Overview 158
11.14 Mindray Medical International Limited 158
11.14.1 Company Overview 158
11.15 Ventana Medical Systems, Inc. 159
11.15.1 Company Overview 159
11.16 DiaSorin S.p.A 159
11.16.1 Company Overview 159
11.17 Qiagen N.V. 159
11.17.1 Company Overview 159
11.18 Gen-Probe Incorporated 160
11.18.1 Company Overview 160
11.19 ARKRAY, Inc. 160
11.19.1 Company Overview 160
11.20 Phadia AB 160
11.20.1 Company Overview 160
11.21 Techno Medica Co., Ltd. 161
11.21.1 Company Overview 161
11.22 Cosmo Bio Co., Ltd. 161
11.22.1 Company Overview 161
11.23 Eiken Chemical Co.,Ltd. 162
11.23.1 Company Overview 162
11.24 Precision System Science Co., Ltd. 162
11.24.1 Company Overview 162
12 In Vitro Diagnostics Market Pipeline Products 163
12.1 Clinical Chemisty Market Pipeline Products 163
12.2 Immuno Chemistry Market Pipeline Products 165
12.3 Haematology Market Pipeline Products 166
12.4 Infectious Immunology Market Pipeline Products 167
12.5 Microbiology Culture Market Pipeline Products 169
12.6 Histology and Cytology Market Pipeline Products 170
12.7 Genetic Testing Market Pipeline Products 171
13 Financial Deals Landscape 173
13.1 Acquisition 173
13.1.1 Beckman Coulter Completes Acquisition Of Olympus-DS From OLYMPUS 173
13.2 Partnerships 175
13.2.1 BIOCIUS Life Sciences Enters Into Distribution Agreement With Wako Pure Chemical Industries 175
13.2.2 QIAGEN Enters Into Distribution Agreement With Celera 176
13.2.3 Sequenom Enters Into Licensing Agreement With Optherion 177
13.2.4 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 178
13.2.5 Epithelix Enters Into Distribution Agreement With Iwaki & Co. 179
13.2.6 OraSure Technologies Enters Into An Agreement With Roche Diagnostics 180
13.2.7 IRIS International Enters Into Exclusive Distribution Agreement With Fujirebio 181
14 Recent Developments 182
14.1 Strategy And Business Planning 182
14.1.1 Dec 15, 2009: Covance Opens New Clinical Development Offices In South Korea And India, Expands Offices In Japan And Hong Kong 182
14.2 Government and Public Interest 183
14.2.1 Mar 25, 2010: New Test Takes Guesswork Out Of Diagnosing Early Stage Alzheimer’s Disease 183
14.2.2 Mar 25, 2010: New Test Helps Diagnose And Treat Early Stage Alzheimer’s Disease 183
14.3 Product News 184
14.3.1 May 18, 2010: Accumetrics Distributes VerifyNow System In Japan Through Medico’s Hirata 184
14.3.2 Dec 10, 2009: Siemens Introduces CLINITEK Status+ Analyzer And CLINITEK Status Connect System 184
14.3.3 Dec 08, 2009: DNA Testing Identifies T-Cell Lymphopenia In Infant 185
15 Appendix 187
15.1 Definitions of Markets Covered in the Report 188
15.1.1 In Vitro Diagnostics 188
15.2 Research Methodology 196
15.3 Secondary Research 197
15.4 Primary Research 197
15.5 Models 198
15.6 Forecasts 198
15.7 Expert Panels 198
15.8 GlobalData Consulting 198
15.9 Currency Conversion 199
15.10 Contact Us 199
15.11 Disclaimer 199
Browse complete Report on: http://www.reportsandreports.com/market-reports/japan-in-vitro-diagnostics-market-outlook-to-2016/
Browse all Medical Devices Market Research Reports on: http://www.reportsandreports.com/market-research/medical-devices/
Browse all GlobalData Market Research Reports on: http://www.reportsandreports.com/Publishers/globaldata/
Browse all Latest Report on:
http://www.reportsandreports.com/LatestReport.aspx
Related Reports:
India In Vitro Diagnostics Market Outlook to 2016
http://www.reportsandreports.com/market-reports/india-in-vitro-diagnostics-market-outlook-to-2016/
China In Vitro Diagnostics Market Outlook to 2016
http://www.reportsandreports.com/market-reports/china-in-vitro-diagnostics-market-outlook-to-2016/
Germany In Vitro Diagnostics Market Outlook to 2016
http://www.reportsandreports.com/market-reports/germany-in-vitro-diagnostics-market-outlook-to-2016/
About us
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/